News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,560 Results
Type
Article (2284)
Company Profile (12)
Press Release (105264)
Multimedia
Podcasts (7)
Webinars (4)
Section
Business (32670)
Career Advice (187)
Deals (10937)
Drug Delivery (5)
Drug Development (10210)
Employer Resources (8)
FDA (1692)
Job Trends (2118)
News (55424)
Policy (3672)
Tag
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (170)
Adcomms (5)
Allergies (5)
Alliances (7462)
ALS (11)
Alzheimer's disease (276)
Antibody-drug conjugate (ADC) (9)
Approvals (1690)
Artificial intelligence (19)
Autoimmune disease (1)
Automation (2)
Bankruptcy (124)
Best Places to Work (1892)
BIOSECURE Act (1)
Biosimilars (9)
Biotechnology (12)
Bladder cancer (12)
Brain cancer (5)
Breast cancer (37)
Cancer (355)
Cardiovascular disease (12)
Career advice (159)
Career pathing (1)
CAR-T (18)
Cell therapy (58)
Cervical cancer (2)
Clinical research (8521)
Collaboration (91)
Compensation (75)
Complete response letters (1)
COVID-19 (189)
CRISPR (4)
C-suite (58)
Cystic fibrosis (21)
Data (397)
Denatured (6)
Depression (5)
Diabetes (44)
Diagnostics (1079)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (9)
Drug pricing (7)
Duchenne muscular dystrophy (7)
Earnings (10610)
Editorial (4)
Employer branding (2)
Employer resources (7)
Events (16108)
Executive appointments (202)
FDA (1878)
Featured Employer (5)
Frontotemporal dementia (1)
Funding (186)
Gene editing (12)
Generative AI (1)
Gene therapy (27)
GLP-1 (51)
Government (350)
Guidances (8)
Healthcare (3133)
IgA nephropathy (3)
Immunology and inflammation (12)
Indications (4)
Infectious disease (211)
Inflammatory bowel disease (26)
Influenza (12)
Intellectual property (17)
Interviews (32)
IPO (5787)
IRA (5)
Job creations (279)
Job search strategy (135)
Layoffs (25)
Leadership (3)
Legal (1038)
Liver cancer (8)
Lung cancer (48)
Lymphoma (17)
Management (1)
Manufacturing (31)
MASH (11)
Medical device (2502)
Medtech (2502)
Mergers & acquisitions (5481)
Metabolic disorders (95)
Multiple sclerosis (13)
NASH (1)
Neurodegenerative disease (10)
Neuroscience (354)
NextGen: Class of 2025 (1248)
Non-profit (375)
Northern California (531)
Now hiring (4)
Obesity (40)
Opinion (8)
Ovarian cancer (11)
Pain (13)
Pancreatic cancer (31)
Parkinson's disease (32)
Partnered (4)
Patents (49)
Patient recruitment (18)
Peanut (4)
People (13141)
Pharmacy benefit managers (1)
Phase I (2780)
Phase II (4166)
Phase III (2542)
Pipeline (275)
Policy (14)
Postmarket research (167)
Preclinical (1132)
Press Release (1)
Prostate cancer (12)
Psychedelics (6)
Radiopharmaceuticals (55)
Rare diseases (51)
Real estate (619)
Recruiting (2)
Regulatory (2555)
Reports (6)
Research institute (208)
Resumes & cover letters (23)
RSV (5)
Schizophrenia (13)
Series A (31)
Series B (19)
Sickle cell disease (10)
Southern California (548)
Special edition (1)
Spinal muscular atrophy (3)
Sponsored (3)
Startups (850)
State (1)
Stomach cancer (3)
Supply chain (10)
Tariffs (1)
United States (5118)
Vaccines (78)
Venture capitalists (5)
Weight loss (14)
Women's health (5)
Date
Today (38)
Last 7 days (145)
Last 30 days (513)
Last 365 days (6843)
2025 (2086)
2024 (7617)
2023 (8982)
2022 (10616)
2021 (11786)
2020 (10729)
2019 (7625)
2018 (5923)
2017 (5287)
2016 (4284)
2015 (5768)
2014 (3944)
2013 (3176)
2012 (3350)
2011 (2998)
2010 (2647)
Location
Africa (37)
Alabama (2)
Arizona (28)
Arkansas (3)
Asia (5961)
Australia (942)
California (1339)
Canada (294)
China (78)
Colorado (71)
Connecticut (51)
Delaware (13)
Europe (9494)
Florida (299)
Georgia (36)
Idaho (8)
Illinois (73)
India (2)
Indiana (79)
Iowa (1)
Japan (18)
Kansas (21)
Kentucky (1)
Maine (35)
Maryland (160)
Massachusetts (911)
Michigan (83)
Minnesota (50)
Mississippi (2)
Missouri (16)
Montana (2)
Nebraska (4)
Nevada (30)
New Hampshire (11)
New Jersey (449)
New Mexico (4)
New York (457)
North Carolina (243)
Northern California (531)
Ohio (34)
Oregon (4)
Pennsylvania (317)
Rhode Island (5)
South America (101)
South Carolina (6)
South Dakota (1)
Southern California (548)
Tennessee (29)
Texas (227)
Utah (49)
Virginia (29)
Washington D.C. (4)
Washington State (86)
West Virginia (2)
Wisconsin (12)
107,560 Results for "orbimed advisors llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.
November 27, 2023
·
4 min read
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
January 10, 2024
·
1 min read
Press Releases
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
February 3, 2025
·
5 min read
Biotech Beach
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
MDxHealth SA announced its financial results for the first quarter ended March 31, 2024 and the closing of a new debt facility with OrbiMed.
May 1, 2024
·
12 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS
February 17, 2025
·
4 min read
Press Releases
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
April 29, 2025
·
3 min read
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
September 30, 2024
·
15 min read
1 of 10,756
Next
